BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 18422781)

  • 1. Results of bone marrow examination in 275 patients with histological features that suggest an indolent type of cutaneous B-cell lymphoma.
    Senff NJ; Kluin-Nelemans HC; Willemze R
    Br J Haematol; 2008 Jul; 142(1):52-6. PubMed ID: 18422781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow examination has limited value in the staging of patients with an anaplastic large cell lymphoma first presenting in the skin. Retrospective analysis of 107 patients.
    Benner MF; Willemze R
    Br J Dermatol; 2008 Nov; 159(5):1148-51. PubMed ID: 18782320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas.
    Zinzani PL; Quaglino P; Pimpinelli N; Berti E; Baliva G; Rupoli S; Martelli M; Alaibac M; Borroni G; Chimenti S; Alterini R; Alinari L; Fierro MT; Cappello N; Pileri A; Soligo D; Paulli M; Pileri S; Santucci M; Bernengo MG;
    J Clin Oncol; 2006 Mar; 24(9):1376-82. PubMed ID: 16492713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine bone marrow biopsy in the initial evaluation of primary cutaneous B-cell lymphoma does not appear justified.
    Quereux G; Frot AS; Brocard A; Leux C; Renaut JJ; Dreno B
    Eur J Dermatol; 2009; 19(3):216-20. PubMed ID: 19251565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles.
    Arcaini L; Paulli M; Boveri E; Vallisa D; Bernuzzi P; Orlandi E; Incardona P; Brusamolino E; Passamonti F; Burcheri S; Schena C; Pascutto C; Cavanna L; Magrini U; Lazzarino M
    Cancer; 2004 Jan; 100(1):107-15. PubMed ID: 14692030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymptomatic bone marrow involvement in patients presenting with cutaneous marginal zone B-cell lymphoma.
    Bathelier E; Thomas L; Balme B; Coiffier B; Salles G; Berger F; Ffrench M; Sebban C; Biron P; Dalle S
    Br J Dermatol; 2008 Aug; 159(2):498-500. PubMed ID: 18547317
    [No Abstract]   [Full Text] [Related]  

  • 7. Stage IV marginal zone B-cell lymphoma--prognostic factors and the role of rituximab: Consortium for Improving Survival of Lymphoma (CISL) study.
    Oh SY; Kim WS; Kim JS; Kim SJ; Lee S; Lee DH; Won JH; Hwang IG; Kim MK; Lee SI; Chae YS; Yang DH; Kang HJ; Choi CW; Park J; Kim HJ; Kwon JH; Lee HS; Lee GW; Eom HS; Kwak JY; Suh C; Kim HJ
    Cancer Sci; 2010 Nov; 101(11):2443-7. PubMed ID: 20831770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Marginal zone B-cell lymphoma affecting the skin: histological and phenotypic study of 49 cases].
    Bathelier E; Thomas L; Balme B; Coiffier B; Berger F; Ffrench M; Salles G; Dalle S
    Ann Dermatol Venereol; 2008 Nov; 135(11):748-52. PubMed ID: 19061653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligoclonal non-neoplastic B cell expansion is the key feature of type II mixed cryoglobulinemia: clinical and molecular findings do not support a bone marrow pathologic diagnosis of indolent B cell lymphoma.
    De Vita S; De Re V; Gasparotto D; Ballarè M; Pivetta B; Ferraccioli G; Pileri S; Boiocchi M; Monteverde A
    Arthritis Rheum; 2000 Jan; 43(1):94-102. PubMed ID: 10643704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers.
    Senff NJ; Hoefnagel JJ; Jansen PM; Vermeer MH; van Baarlen J; Blokx WA; Canninga-van Dijk MR; Geerts ML; Hebeda KM; Kluin PM; Lam KH; Meijer CJ; Willemze R
    J Clin Oncol; 2007 Apr; 25(12):1581-7. PubMed ID: 17353548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of marginal zone lymphoma involving bone marrow.
    Kent SA; Variakojis D; Peterson LC
    Am J Clin Pathol; 2002 May; 117(5):698-708. PubMed ID: 12090417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applying the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome in primary cutaneous marginal zone lymphoma.
    Gerami P; Wickless SC; Rosen S; Kuzel TM; Ciurea A; Havey J; Guitart J
    J Am Acad Dermatol; 2008 Aug; 59(2):245-54. PubMed ID: 18486274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases.
    Grange F; Beylot-Barry M; Courville P; Maubec E; Bagot M; Vergier B; Souteyrand P; Machet L; Dalac S; Esteve E; Templier I; Delaporte E; Avril MF; Robert C; Dalle S; Laroche L; Delaunay M; Joly P; Wechsler J; Petrella T
    Arch Dermatol; 2007 Sep; 143(9):1144-50. PubMed ID: 17875875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal gammopathy in extranodal marginal zone lymphoma (ENMZL) correlates with advanced disease and bone marrow involvement.
    Asatiani E; Cohen P; Ozdemirli M; Kessler CM; Mavromatis B; Cheson BD
    Am J Hematol; 2004 Oct; 77(2):144-6. PubMed ID: 15389912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous B-cell lymphoma: pathological spectrum and clinical outcome in 51 consecutive patients.
    Sah A; Barrans SL; Parapia LA; Jack AS; Owen RG
    Am J Hematol; 2004 Apr; 75(4):195-9. PubMed ID: 15054808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous involvement with marginal zone lymphoma.
    Gerami P; Wickless SC; Querfeld C; Rosen ST; Kuzel TM; Guitart J
    J Am Acad Dermatol; 2010 Jul; 63(1):142-5. PubMed ID: 20462658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indolent cutaneous B-cell lymphoma: diagnosis and treatment 2012.
    Santucci M; Grandi V; Maio V; Delfino C; Alterini R; Pimpinelli N
    G Ital Dermatol Venereol; 2012 Dec; 147(6):581-8. PubMed ID: 23149704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is bone marrow biopsy always indicated in patients with primary cutaneous marginal zone B-cell lymphoma?
    Muniesa C; Hernández-Machín B
    Actas Dermosifiliogr; 2013 Oct; 104(8):667-71. PubMed ID: 23954046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The applicability and prognostic value of the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: results on a large cohort of primary cutaneous B-cell lymphomas and comparison with the system used by the Dutch Cutaneous Lymphoma Group.
    Senff NJ; Willemze R
    Br J Dermatol; 2007 Dec; 157(6):1205-11. PubMed ID: 17941944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometry in the bone marrow staging of mature B-cell neoplasms.
    Stacchini A; Demurtas A; Godio L; Martini G; Antinoro V; Palestro G
    Cytometry B Clin Cytom; 2003 Jul; 54(1):10-8. PubMed ID: 12827663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.